Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors ...

Hims & Hers Stock Surges 50% In One Week Thanks to RFK Jr.’s Peptide Push ...

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks With Monster Returns. Hims & Hers saw its share prices jump by 48 ...

Hims & Hers Health Inc HIMS shares are trading higher on Monday as traders lean into optimism around a potentially friendlier ...

Hims may have a chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the ...

By Sneha S K April 16 (Reuters) - Shares of Hims & Hers Health rose more than 7% on Thursday as analysts said the U.S. drug ...

Hims & Hers (HIMS) stock is down ~40% YTD but remains a "Buy." Learn why compressed valuation and Eucalyptus-led Europe/Japan ...

Shares of Hims & Hers Health (NYSE:HIMS) rose more than 8% to about $26 after the US Food and Drug Administration (FDA) moved ...

Hims & Hers Health (NYSE:HIMS) just got a fresh look from Bank of America, which raised its price target on the stock to $25 from $21 while maintaining a Neutral rating. The catalyst: the FDA took a ...

Hims & Hers Health (NYSE:HIMS), a consumer-focused telehealth platform offering prescription and non-prescription health products, closed Thursday at $26.98, up 11.07%. The stock moved higher as ...

Hims & Hers (HIMS) shares rose as much as 11% in premarket trading on Thursday, on track to extend their ~14% rally on ...